-
Morocco overcome historic Haiti goals to roll into World Cup last 32
-
Bosnia beat Qatar to reach World Cup knockout stages for first time
-
Twin earthquakes in Venezuela destroy buildings, sow panic
-
Brazil advance at World Cup as Swiss, Canada reach last 32
-
Vinicius Junior sparkles as Brazil beat Scots to reach World Cup last 32
-
Morocco overcome historic Haiti goals to maintain World Cup momentum
-
Two powerful earthquakes strike Venezuela, destroying buildings
-
ICC judges sue Trump over 'draconian' sanctions
-
Australia teen social media ban has little impact: research
-
Space shuttle ready for new mission in California
-
Modigliani nude sets European record at London auction
-
Tunisia coach Renard demands pride in final World Cup outing
-
Trump seeks $88 bn in extra funding, mostly for Iran war
-
Switzerland, Canada advance as Brazil eye last 32
-
Wyatt-Hodge stars as England ease into Women's T20 World Cup semi-finals
-
Bosnia in strong position to reach last 32, Qatar out of World Cup
-
Switzerland down World Cup co-hosts Canada to top Group B, both progress
-
Brent falls below $75 as Nasdaq drops for 3rd straight day
-
'New rules': life in world epicentre of jihadist terror
-
Korda chases 3rd straight major at Women's PGA Championship
-
Trump clashes with Republicans in testy Capitol visit
-
Zimbabwe Senate approves bill to extend presidential term
-
Scheffler says PGA Tour headed 'in right direction' with two-tier system
-
Pulisic fitness boost as US seek knockout momentum against Turkey
-
Mamdani-backed leftist candidates win New York Democratic primaries
-
Hantavirus outbreak should formally end on July 2: WHO
-
Britain's Draper continues promising start under Andy Murray
-
Hong Kong arrests two for allegedly selling 'seditious' material
-
Laporte wary of Uruguay will to avoid World Cup exit against Spain
-
US promises to protect Gulf states' interests in Iran talks
-
Major Nigeria police reform edges forward with senate approval
-
Trials of two Ebola treatments to start in DRC next week: WHO
-
Trump consolidates rightward shift in Latin America
-
Judge asks why Kennedy Center covering facade after Trump's name removed
-
Olympics to offer all Games competitors $10,000 grants
-
Germany sinks troubled warship project in blow to naval ambitions
-
Left-wing candidate concedes tight Colombia election
-
US health deals cause trouble for Kenya govt
-
Stocks rebound after tech rout, Brent falls below $75
-
Socialism with a twist or crony capitalism? Cuban reforms spark debate
-
Berlin unveils monument to Jehovah's Witnesses murdered by Nazis
-
'Inhumane': Gaza flotilla activists recount Israeli detention ordeal
-
'Fingerprints' of black hole's event horizon detected for first time
-
Spurs sign Dubravka as goalkeeper cover
-
Verstappen seeking home boost with Red Bull upgrades
-
Stocks steady after tech rout, Brent falls below $75
-
'You have to work': Riders brave Rome heat for survival
-
England captain Stokes 'man enough' to apologise for curfew breach
-
France detects first Ebola case outside Africa in current outbreak
-
England captain Stokes 'man enough' to apologise after curfew breach
MYTRT Announces UK Digital Healthcare Platform for Testosterone Testing and Doctor-Led Hormonal Health Services
LONDON, UK / ACCESS Newswire / May 23, 2026 / MYTRT, a UK-based digital healthcare platform, has announced the launch of a service for people seeking information, testing and clinical assessment relating to hormonal health. The platform includes home blood testing options, clinical review of results and care pathways for men who may require further assessment for low testosterone.

The service has been developed to support men who want to understand whether symptoms such as tiredness, low mood, reduced libido or changes in concentration may be associated with testosterone levels. These symptoms can have a range of causes, and MYTRT's pathway is intended to provide structured testing, result interpretation and next-step guidance from healthcare professionals.
MYTRT's testosterone testing service includes a home blood test option that measures testosterone-related biomarkers. Results are reviewed as part of a clinical pathway, rather than being returned only as raw laboratory values. Where further assessment is appropriate, patients may be offered a consultation to discuss their results, medical history and available treatment options.
Testosterone Replacement Therapy, commonly referred to as TRT, is a medical treatment that may be prescribed for men who have symptoms and clinically confirmed low testosterone. Treatment decisions are made following clinical review and are based on the individual patient's circumstances, test results and medical history. MYTRT states that any treatment provided through its platform is supported by ongoing monitoring and follow-up.
How the MYTRT Care Pathway Works
The MYTRT pathway is designed to move patients through testing, clinical review and, where appropriate, ongoing care. Patients begin by selecting a blood testing option. After the sample has been analysed, the results are reviewed and explained through the platform. If the findings indicate that further assessment may be needed, patients can discuss the results with a clinician and consider the next steps.
For patients who are already receiving testosterone replacement therapy, MYTRT also provides a transfer pathway into its doctor-led service. The pathway is intended for men who wish to have their existing treatment reviewed and monitored through a structured clinical service. Patients are assessed individually before any treatment or monitoring plan is agreed.
Doctor-Led Hormonal Health Support
"We created MYTRT to provide a structured route for people who want to understand their hormonal health and, where clinically appropriate, access doctor-led care," said Dr Raphael Olaiya, GP and TRT Doctor at MYTRT. "Our focus is on helping patients understand their results, receive clear guidance and make informed decisions with clinical support."
MYTRT states that each patient pathway is based on clinical assessment, result interpretation and ongoing monitoring. Treatment options may include topical, oral or injectable medication where these are clinically appropriate. Individual suitability, treatment choice and follow-up requirements are considered as part of the consultation and monitoring process.
Broader Biomarker Testing
Alongside testosterone testing, MYTRT offers wider biomarker testing options for people who want a broader view of selected health markers. These tests are available to both men and women and may be used to support discussions with healthcare professionals about general health, lifestyle and follow-up assessment.
Patients who complete broader testing can use their results to inform conversations with their own healthcare provider or seek further clinical guidance through the MYTRT platform. The company states that the service is intended to support information, monitoring and clinical decision-making rather than replace emergency, urgent or in-person medical care where that is required.
About MYTRT
MYTRT is a UK-based digital healthcare platform providing hormonal health services, including testosterone testing, clinical review and doctor-led care pathways. The platform supports men seeking assessment for low testosterone and offers wider biomarker testing for people who want additional health information. MYTRT's services are designed to combine home testing, result interpretation and ongoing clinical support where appropriate.
For more information, visit https://www.mytrt.com.
Media Contact
Organization: MYTRT
Contact Person Name: Raphael Olaiya
Website: https://www.mytrt.com/
Email: [email protected]
City: London
Country: United Kingdom
SOURCE: MYTRT
View the original press release on ACCESS Newswire
A.Williams--AT